{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-031371","form_type":"8-K","ticker":"KNSA","cik":"0001730430","company_name":"Kiniksa Pharmaceuticals International, plc","filed_at":"2023-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.341099+00:00","generated_at":"2026-06-18T04:37:13.738504+00:00","sec_items":["7.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Kiniksa reveals no exposure to Silicon Valley Bank; no deposits or securities held","bullets":["Kiniksa confirmed it did not hold cash deposits or securities with SVB.","Company also stated it has no business relationship with SVB.","Disclosure made on March 10, 2023, amid SVB liquidity crisis.","This voluntary FD disclosure reassures investors of zero SVB exposure."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-031371","json":"https://secwatch.observer/filing/0001104659-23-031371.json","markdown":"https://secwatch.observer/filing/0001104659-23-031371.md","text":"https://secwatch.observer/filing/0001104659-23-031371.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1730430/000110465923031371/0001104659-23-031371-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1730430/000110465923031371/tm239243d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:37:13.738504+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}